Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy
Clinical Drug Investigation · 2026-07 · 46 (7) · 771-782
DOI: 10.1007/s40261-026-01559-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, online erschienen am 12.05.2026. Verfasst von Giuseppe Musumeci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Struttura Complessa di Cardiologia, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy. Hauptthemen laut MEDLINE: PCSK9 Inhibitors, Atherosclerosis, Anticholesteremic Agents, Antibodies, Monoclonal. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Struttura Complessa di Cardiologia, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy.
- AdRes HE&OR, Turin, Italy.
- Department of General Medicines and Market Access, Sanofi, Reading, UK.
- AdRes HE&OR, Turin, Italy. m.povero@adreshe.com.
Zitieren
APA
Musumeci, G., Pradelli, L., Lee, K., & Povero, M. (2026). Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy. Clinical Drug Investigation, 46(7), 771-782. https://doi.org/10.1007/s40261-026-01559-7
Vancouver
Musumeci G, Pradelli L, Lee K, Povero M. Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy. Clinical Drug Investigation. 2026;46(7):771-782. doi:10.1007/s40261-026-01559-7
BibTeX
@article{Musumeci2026,
author = {Musumeci, Giuseppe and Pradelli, Lorenzo and Lee, Kelly and Povero, Massimiliano},
title = {Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy},
journal = {Clinical Drug Investigation},
year = {2026},
volume = {46},
number = {7},
pages = {771--782},
doi = {10.1007/s40261-026-01559-7}
}
EUVIMED